Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol in Chronic Chagas Cardiomyopathy
NCT01557140Phase 4Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- May 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chagas cardiomyopathy (CCC) comparing RASi plus carvedilol with RASi plus placebo (2 arms). Primary endpoint: Left Ventricular Ejection Fraction at 8 months. Started May 2003; status: completed.
02
Drugs
carvedilol
03
Conditions
Chagas cardiomyopathy (CCC)
Beyond the preview
Go deeper on NCT01557140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557140.